SANTEN PHARMACEUTICAL CO., LTD.
参天製薬株式会社
Ticker: 4536 · Updated Jun 18, 2026 15:05
Last Updated
Jun 18, 2026 15:05
Period:
Display Units:
Figures:
¥ billions · Annual
Tip: select a row to chart its trend.
Income Statement
Income Statement IFRS Consolidated | FY2016 Mar 31, 2017 Summary only Restated later | FY2017 Mar 31, 2018 Summary only | FY2018 Mar 31, 2019 | FY2019 Mar 31, 2020 | FY2020 Mar 31, 2021 Restated later | FY2021 Mar 31, 2022 | FY2022 Mar 31, 2023 | FY2023 Mar 31, 2024 | FY2024 Mar 31, 2025 | FY2025 Mar 31, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| 199.1 | 224.9 | 234.0 | 241.6 | 249.6 | 266.3 | 279.0 | 302.0 | 300.0 | 291.6 | |
YoY Change | Not available | 13.0% | 4.0% | 3.2% | 3.3% | 6.7% | 4.8% | 8.2% | -0.6% | -2.8% |
| Not available | Not available | 90.8 | 94.8 | 98.2 | 109.7 | 113.0 | 123.3 | 129.0 | 121.9 | |
| Not available | Not available | 143.3 | 146.7 | 151.4 | 156.6 | 166.1 | 178.7 | 171.0 | 169.7 | |
YoY Change | Not available | Not available | Not available | 2.4% | 3.2% | 3.4% | 6.1% | 7.6% | -4.3% | -0.8% |
| Not available | Not available | 71.3 | 73.4 | 79.6 | 84.5 | 96.3 | 91.5 | 88.0 | 89.6 | |
| Not available | Not available | 4.0 | 0.4 | 16.0 | 1.0 | 3.5 | 1.5 | 0.6 | 7.0 | |
| Not available | Not available | 0.2 | 7.0 | 40.9 | 1.1 | 38.6 | 15.3 | 3.9 | 4.4 | |
| Not available | Not available | 45.1 | 33.5 | 12.9 (Restated in the FY2021 report: 12.2) | 35.9 | -3.1 | 38.5 | 46.9 | 47.8 | |
YoY Change | Not available | Not available | Not available | -25.6% | -61.5% | 194.5% | n/m: Not meaningful: the base period is a loss or zero, or the figure swung from a profit to a loss. | n/m: Not meaningful: the base period is a loss or zero, or the figure swung from a profit to a loss. | 21.6% | 2.0% |
| Not available | Not available | 0.9 | 1.0 | 1.3 | 2.5 | 1.2 | 1.6 | 4.0 | 1.6 | |
| Not available | Not available | 2.9 | 2.4 | 1.5 | 1.2 | 1.5 | 2.7 | 2.7 | 2.0 | |
| 31.8 (Restated in the FY2017 report: 30.1) | 39.3 | 43.1 | 32.1 | 12.4 (Restated in the FY2021 report: 11.7) | 35.6 | -5.8 | 29.9 | 47.5 | 47.4 | |
| 11.2 | 10.4 | 5.8 (Restated in the FY2021 report: 2.6) | 8.4 | 9.2 | 3.2 | 11.6 | 9.9 | |||
| Not available | Not available | 31.9 | 21.7 | 6.6 (Restated in the FY2021 report: 9.1) | 27.2 | -15.0 | 26.7 | 35.9 | 37.6 | |
| -2.5 | -1.5 | 8.7 (Restated in the FY2021 report: 8.8) | 11.4 | 9.3 | 13.3 | -6.9 | 17.9 | |||
| Not available | Not available | 29.5 | 20.2 | 15.4 (Restated in the FY2021 report: 18.0) | 38.6 | -5.7 | 40.0 | 29.0 | 55.5 |
Notes
- Figures in ¥ billions
- Financial data sourced from official Japanese regulatory disclosures
- Each column header links to its source filing; select a line to see its XBRL elements.
- Each year is shown as filed in that year's own report. Switch to Restated to see a year as the next year's report restated it; restated cells are marked R.
- Displaying 10 of 10 periods
- YoY Change compares each period with the same period a year earlier. A full year's change uses the prior year as that year's own report restates it (cells marked R), so it can differ from the change between the two columns as filed.
- Columns marked “Summary only”: for these years the filing tags only its summary of key figures (主要な経営指標等) in machine-readable form, as is usual for US-GAAP filers, so line items such as operating income are not available. The figures shown are the company’s own consolidated totals.
- FY = fiscal year, named by the calendar year it starts in; the month in brackets is when it ends (FY2025 ends Mar 2026 for a March year-end). FY2025 (Mar 2026) runs Apr 1, 2025 – Mar 31, 2026.
Get this data via the API
curl https://hachiquant.com/api/v1/companies/4536/income-statements?view=canonical curl https://hachiquant.com/api/v1/companies/4536/metrics No key needed. API reference